| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Alamar Biosciences, Inc.
13G
ALMR · 010911105
|
10.2% |
8/11/2026
Event 6/30/2026
|
||||
| Qiming Corporate GP VI, Ltd | 10.2% | |||||
| Qiming Venture Partners VI, L.P. | 9.9% | |||||
| Qiming Managing Directors Fund VI, L.P. | 0.3% | |||||
| Qiming GP VIII, LLC | 2.3% | |||||
| Qiming Venture Partners VIII Investments, LLC | 2.3% | |||||
| Qiming GP VIII-HC, LLC | 2.8% | |||||
| Qiming Venture Partners VIII-HC, L.P. | 2.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.